Literature DB >> 21873346

The role of hyperbaric oxygen in the treatment of diabetic foot ulcers.

Elisavet K Tiaka1, Nikolaos Papanas, Anastassios C Manolakis, Efstratios Maltezos.   

Abstract

Diabetic foot ulcers are still extremely difficult to heal. Therefore, therapeutic options to improve healing rates are continuously being explored. Hyperbaric oxygen (HBO) has been used in addition to standard treatment of the diabetic foot for more than 20 years. Evidence suggests that HBO reduces amputation rates and increases the likelihood of healing in infected diabetic foot ulcers, in association with improved tissue oxygenation, resulting in better quality of life. Nonetheless, HBO represents an expensive modality, which is only available in few centers. Moreover, adverse events necessitate a closer investigation of its safety. Finally, it is not entirely clear which patients stand to benefit from HBO and how these should be selected. In conclusion, HBO appears promising, but more experience is needed before its broad implementation in the routine care of the diabetic foot.

Entities:  

Mesh:

Year:  2011        PMID: 21873346     DOI: 10.1177/0003319711416804

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  12 in total

Review 1.  Topical oxygen therapy & micro/nanobubbles: a new modality for tissue oxygen delivery.

Authors:  Lohrasb R Sayadi; Derek A Banyard; Mary E Ziegler; Zaidal Obagi; Jordyne Prussak; Michael J Klopfer; Gregory Rd Evans; Alan D Widgerow
Journal:  Int Wound J       Date:  2018-01-05       Impact factor: 3.315

2.  Comments on Margolis et al. Lack of effectiveness of hyperbaric oxygen therapy for the treatment of diabetic foot ulcer and the prevention of amputation.

Authors:  Magnus Löndahl; Per Katzman
Journal:  Int Wound J       Date:  2013-06-03       Impact factor: 3.315

Review 3.  Factors That Impair Wound Healing.

Authors:  Kristin Anderson; Rose L Hamm
Journal:  J Am Coll Clin Wound Spec       Date:  2014-03-24

4.  Hyperbaric oxygen preconditioning protects skin from UV-A damage.

Authors:  Ashley M Fuller; Charles Giardina; Lawrence E Hightower; George A Perdrizet; Cassandra A Tierney
Journal:  Cell Stress Chaperones       Date:  2012-08-03       Impact factor: 3.667

5.  The role of nerve growth factor in the prophylaxis and treatment of diabetic foot ulcers.

Authors:  Elisavet K Tiaka; Nikolaos Papanas; Anastassios C Manolakis; Efstratios Maltezos
Journal:  Int J Burns Trauma       Date:  2011-09-03

6.  Clinical effectiveness of hemoglobin spray (Granulox®) as adjunctive therapy in the treatment of chronic diabetic foot ulcers.

Authors:  Sharon D Hunt; Fredrik Elg
Journal:  Diabet Foot Ankle       Date:  2016-11-07

7.  Scorpion Venom Active Polypeptide May Be a New External Drug of Diabetic Ulcer.

Authors:  Ting Wan; Luocheng Li; Zhanyong Zhu; Siyang Liu; Yueqiang Zhao; Mosheng Yu
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-29       Impact factor: 2.629

Review 8.  Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing.

Authors:  Danielle Dixon; Michael Edmonds
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

9.  Determinants of microbial load in infected diabetic foot ulcers: a pilot study.

Authors:  M Demetriou; N Papanas; M Panopoulou; K Papatheodorou; E Maltezos
Journal:  Int J Endocrinol       Date:  2013-06-26       Impact factor: 3.257

Review 10.  Diabetes and Wound Angiogenesis.

Authors:  Uzoagu A Okonkwo; Luisa A DiPietro
Journal:  Int J Mol Sci       Date:  2017-07-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.